ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,855Medicare Part D Prescriptions Filled, Including Refills

Rank: 133 out of 944

$528K Total Retail Price of All Prescriptions

Rank: 188 out of 944

527 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 527 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

16% of this provider’s 527 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 7,836 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
SIMVASTATIN 555 438 1 1
LISINOPRIL 539 397 2 3
OMEPRAZOLE 408 242 3 4
LEVOTHYROXINE SODIUM 379 328 4 2
HYDROCODONE-ACETAMINOPHEN 296 167 S3 5 10
FUROSEMIDE 274 233 6 6
AMLODIPINE BESYLATE 267 216 7 5
ATENOLOL 266 208 8 11
WARFARIN SODIUM 259 166 9 7
HYDROCHLOROTHIAZIDE 250 211 10 9
ALENDRONATE SODIUM 248 199 11 20
METOPROLOL SUCCINATE 241 195 12 14
JANTOVEN 189 155 13 139
POTASSIUM CHLORIDE 184 152 14 15
LOSARTAN POTASSIUM 177 150 15 16
GABAPENTIN 170 109 16 18
ATORVASTATIN CALCIUM 165 100 17 13
METFORMIN HCL 157 124 18 12
METOPROLOL TARTRATE 137 105 19 8
GLIMEPIRIDE 133 123 20 47
TRAZODONE HCL 126 70 21 45
FLUOXETINE HCL 125 86 22 48
TRAMADOL HCL 112 35 23 21
MIRTAZAPINE 108 100 24 35
ADVAIR DISKUS 95 63 25 31
DIOVAN 94 74 26 38
CRESTOR 94 53 26 28
ALLOPURINOL 87 75 28 22
ZOLPIDEM TARTRATE 83 47 29 25
PROAIR HFA 82 52 30 56
CITALOPRAM HBR 81 62 31 19
ENALAPRIL MALEATE 81 80 31 43
IBUPROFEN 80 11 33 140
PRAVASTATIN SODIUM 78 69 34 17
SERTRALINE HCL 77 40 35 23
DONEPEZIL HCL 77 77 35 24
COMBIVENT 73 45 37 107
NAPROXEN 70 48 38 113
SPIRIVA 69 57 39 65
ISOSORBIDE MONONITRATE ER 68 52 40 52
NEXIUM 64 23 41 53
TAMSULOSIN HCL 59 58 42 27
LANTUS SOLOSTAR 58 37 43 61
PAROXETINE HCL 58 31 43 64
PEN NEEDLE 55 38 45 100
LIPITOR 55 28 45 91
DETROL LA 54 51 47 159
POLYETHYLENE GLYCOL 3350 53 41 48 41
OXYBUTYNIN CHLORIDE 51 30 49 94
VENLAFAXINE HCL ER 51 36 49 84
PANTOPRAZOLE SODIUM 50 33 51 34
FENTANYL 50 34 S2 51 57
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 9, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.